Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 6:56 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 553–576 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Endothelial Dysfunction, Arterial Stiffness
Interventions: Acute submaximal exercise; Other
Lead sponsor: Towson University; Other
Eligibility: 18 Years to 29 Years
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Towson, Maryland

Conditions: HIV, Endothelial Dysfunction
Interventions: Not listed
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 8 Years to 30 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Stroke, Mild Cognitive Impairment
Interventions: Transcranial Dirrect Current Stimulation; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 99 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Right Bundle-Branch Block
Interventions: Optimization of CRT Device; Diagnostic Test
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 89 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 2
States / cities: Little Rock, Arkansas • Detroit, Michigan

Conditions: Endometrial Carcinoma, Malignant Uterine Neoplasm, Uterine Corpus Cancer, Uterine Corpus Sarcoma
Interventions: Questionnaire Administration; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 310 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Premature Ejaculation
Interventions: IX-01, Placebo; Drug
Lead sponsor: Ixchelsis Limited; Industry
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 8
States / cities: San Diego, California • Aventura, Florida • West Palm Beach, Florida + 5 more

Conditions: Dementia, Potentially Inappropriate Medication Use, Mild Cognitive Impairment (MCI)
Interventions: e-ALIGN Patient-Portal Deprescribing; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 65 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Uric Acid Kidney Stone Disease
Interventions: Pioglitazone, Placebo; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 21 Years to 99 Years
Enrollment: 172 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Mild Cognitive Impairment, Early Alzheimer's Disease, AD-MCI
Interventions: human Mesenchymal Stem Cells; Biological
Lead sponsor: Bernard (Barry) Baumel; Other
Eligibility: 55 Years to 90 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Cardiac Disease
Interventions: MyoVista wavECG Test; Device
Lead sponsor: Heart Test Laboratories, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 575 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 5
States / cities: La Jolla, California • Boston, Massachusetts • The Bronx, New York + 2 more

Conditions: Chronic Kidney Disease, Kidney Transplant, Coronary Microvascular Dysfunction (CMD), Inflammation
Interventions: Not listed
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Congenital Heart Disease
Interventions: Partial Heart Transplantation, Freshly procured valve; Procedure · Other
Lead sponsor: Duke University; Other
Eligibility: Up to 12 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Still's Disease, Adult-Onset, Systemic Inflammation, Arthritis, Autoinflammatory Syndrome
Interventions: Not listed
Lead sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); NIH
Eligibility: 1 Day to 100 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2050
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
Interventions: Finerenone (Kerendia, BAY94-8862), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 6 Months to 17 Years
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 22
States / cities: Aurora, Colorado • Wilmington, Delaware • Gainesville, Florida + 18 more

Conditions: Cardiovascular Diseases, Hypertension, Cognitive Decline, Diet, Healthy
Interventions: Goode Health Beverage, Vanilla Base Beverage Blend; Dietary Supplement
Lead sponsor: The University of Texas at Arlington; Other
Eligibility: 18 Years to 55 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Arlington, Texas

Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease, Hepatic Steatosis, Liver Disease Parenchymal
Interventions: Quantitative ultrasound (DeepUSFF); Device
Lead sponsor: Seoul National University Hospital; Other
Eligibility: 18 Years and older
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boardman, Ohio

Conditions: Corneal Edema, Corneal Endothelial Dysfunction
Interventions: AURN001, Corneal Endothelial Cells, Y27632; Combination Product · Biological · Drug
Lead sponsor: Aurion Biotech; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 17
States / cities: Little Rock, Arkansas • Los Angeles, California • San Francisco, California + 13 more

Conditions: Ileus
Interventions: Alvimopan; Drug
Lead sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA); Industry
Eligibility: 18 Years and older
Enrollment: 666 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2003
U.S. locations: 1
States / cities: Exton, Pennsylvania

Conditions: Stress Urinary Incontinence
Interventions: Vaginal pessary; Device
Lead sponsor: Liv Labs Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 3
States / cities: Chicago, Illinois • Lake Forest, Illinois • Columbus, Ohio

Conditions: Mild Cognitive Impairment, Caregiver Burden, Mental Health Issue, ADL, Quality of Life
Interventions: rTMS, rTMS+iVCT; Device
Lead sponsor: Central Arkansas Veterans Healthcare System; Federal
Eligibility: 55 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Sudden Cardiac Death, Ventricular Fibrillation, Ventricular Tachycardia, Ventricular Dysfunction, Myocardial Ischemia
Interventions: wearable defibrillator (LifeVest); Device
Lead sponsor: Zoll Medical Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 5
States / cities: Sacramento, California • Atlanta, Georgia • Takoma Park, Maryland + 2 more

Conditions: Alzheimer's Disease, Dementia, Mild Cognitive Impairment
Interventions: PET Scan; Device
Lead sponsor: American College of Radiology; Other
Eligibility: 65 Years and older
Enrollment: 18,488 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Postoperative Complications, Postoperative Cognitive Dysfunction
Interventions: Carotid endarterectomy, Mini Mental Status Examination; Procedure · Diagnostic Test
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Fabry Disease
Interventions: Not listed
Lead sponsor: University of Washington; Other
Eligibility: 1 Day to 90 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 3
States / cities: Decatur, Georgia • Minneapolis, Minnesota • Seattle, Washington

Search by objective public record fields.

Influence of Cardiorespiratory Fitness and Body Composition on Resting and Post-exercise Indices of Vascular Health in Young Adults

Use of EndoPAT for Measurements of Endothelial Dysfunction in HIV Infected Children and Healthy Controls

tDCS for Post-Stroke Cognitive Impairment

Adaptive Cardiac Resynchronization Therapy in Patients With RBBB

Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors

IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)

e-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most

Pathophysiology of Uric Acid Nephrolithiasis

Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.

MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram

The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease

Partial Heart Transplantation

Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions

A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

The Impact of Goode Health Beverage on Markers of Physiological and Neurocognitive Health

Quantitative Ultrasound (RS85 and R20) for Liver Fat Quantification in MASLD Using MRI-PDFF as Reference

A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)

Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/ Postoperative Ileus

Pippa Pessary Study (Clinical Trial)

A rTMS and Virtual Reality Based Cognitive Rehabilitation Program for MCI

LifeVest Post-CABG Registry

Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study

Risk Factors for Complications After Carotid Endarterectomy

Podocyturia - Predictor of Renal Dysfunction in Fabry Nephropathy